{"retracted":false,"update":{"timestamp":1412121600000,"doi":"10.1371/journal.pone.0110098","type":"correction"},"doi":"10.1371/journal.pone.0089349","journal":"PLoS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation"}
